Practice question

p21WAF1/CIP1 encoded by CDKN1A represents broad-spectrum cyclin-dependent kinase inhibitor linking DNA damage response to cell cycle arrest in G1 and G2. Upon double-strand break detection, ATM kinase phosphorylates Chk2 and p53 at serine 15, blocking MDM2-mediated ubiquitination and stabilizing p53. ATR responds to single-stranded DNA coated with RPA. Accumulated p53 binds response elements in CDKN1A promoter, markedly upregulating p21 protein that contains N-terminal CDK inhibitory domain with Cy1 and Cy2 cyclin-binding motifs. p21 inserts into catalytic cleft of cyclin E-CDK2, cyclin D-CDK4/6, and cyclin B-CDK1, blocking ATP binding and preventing phosphorylation of Rb and mitotic substrates. Arrest provides window for base excision repair, nucleotide excision repair, and homologous recombination to restore template integrity before replication or segregation. p21 also directly binds proliferating cell nuclear antigen PCNA, pausing processive DNA synthesis at damaged forks without abolishing repair synthesis. Loss of p21 permits replication of damaged DNA, propagating mutations. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.